Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry

References

• Luisetti M, Campo I, Scabini R, et al. The problems of clinical trials and registries in rare diseases. Respir Med 2010; 104 Suppl 1:S42–44.
   PubMed Web of Science ®Google Scholar
• Janciauskiene SM, Bals R, Koczulla R, et al. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med 2011; 105(8):1129–1139.
   PubMed Web of Science ®Google Scholar
• Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 2004; 59(2):164-9.
   PubMed Web of Science ®Google Scholar
• Blanco I, de Serres FJ, Fernandez-Bustillo E, et al. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J 2006; 27(1):77–84.
   PubMed Web of Science ®Google Scholar
• Piras B, Ferrarotti I, Lara B, et al. Clinical phenotypes of Italian and Spanish patients with alpha1-antitrypsin deficiency. Eur Respir J 2013; 42(1):54–64.
   PubMed Web of Science ®Google Scholar
• Tirado-Conde G, Lara B, Casas F, et al. Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry. Arch Bronconeumol 2011; 47(10):495–503.
   PubMed Web of Science ®Google Scholar
• Koczulla R, Bittkowski N, Andress J, et al. [The German registry of individuals with alpha-1-antitrypsin deficiency–a source for research on patient care]. Pneumologie 2008; 62(11):655–658.
   PubMedGoogle Scholar
• Stockley RA, Luisetti M, Miravitlles M, et al. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. Eur Respir J 2007; 29(3):582–586.
   PubMed Web of Science ®Google Scholar
• Schluchter MD, Stoller JK, Barker AF, et al. Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 2000; 161(3 Pt 1):796–801.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Brantly M, Fleming LE, et al. Formation and current results of a patient-organized registry for alpha(1)-antitrypsin deficiency. Chest 2000; 118(3):843–848.
   PubMed Web of Science ®Google Scholar
• Alpha-1-Antitrypsin Deficiency Registry Study G. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 1998; 158(1):49–59.
   PubMed Web of Science ®Google Scholar
• Greulich T, Ottaviani S, Bals R, et al. Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. Respir Med 2013; 107(9):1400–1408.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Herr C, Ferrarotti I, Jardi R, Rodriguez-Frias F, Luisetti M, et al. Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in three European centres. Eur Respir J 2010; 35(5):960–968.
   PubMed Web of Science ®Google Scholar
• McElvaney NG, Stoller JK, Buist AS, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 1997; 111(2):394–403.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Sandhaus RA, Turino G, et al. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest. 2005; 128(4):1989–1994.
   PubMed Web of Science ®Google Scholar
• Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res J Lab Clin Med 2013; 162(4):208–218.
   Google Scholar
• Ward H, Turner AM, Stockley RA. Spirometric and gas transfer discordance in a alpha1 -antitrypsin deficiency. patient characteristics and progression. Chest 2014; 145(6):1316–1324.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Casanova C, Hernandez C, et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128(4):2012–2016.
   Google Scholar
• Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006; 100(10):1767–1774.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Postma DS, et al. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006; 7:52.
   PubMed Web of Science ®Google Scholar
• Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 2011; 184(4):414–420.
   PubMed Web of Science ®Google Scholar
• Jain NK, Thakkar MS, Jain N, et al. Chronic obstructive pulmonary disease: Does gender really matter? Lung India Official Organ Ind Chest Soc 2011; 28(4):258–262.
   PubMedGoogle Scholar
• Han MK, Postma D, Mannino DM, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007; 176(12):1179–1184.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Campbell AC, Bowers M, Nichol AM. Understanding the social consequences of chronic obstructive pulmonary disease: the effects of stigma and gender. Proc Amer Thorac Soc 2007; 4(8):680–682.
   PubMedGoogle Scholar
• Martinez CH, Raparla S, Plauschinat CA, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Women's Health 2012; 21(12):1267–1274.
   PubMed Web of Science ®Google Scholar
• Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med 2011; 183(3):317–322.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Casanova C, Hernandez C, et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcom 2006; 4:72.
   PubMed Web of Science ®Google Scholar
• Roche N, Deslee G, Caillaud D, et al. Impact of gender on COPD expression in a real-life cohort. Respir Res 2014; 15:20.
   PubMed Web of Science ®Google Scholar
• Wewers MD, Crystal RG. Alpha-1 antitrypsin augmentation therapy. COPD 2013; 10 Suppl 1:64–67.
   PubMedGoogle Scholar